FDA opens safety review of injectable drugs for RSV in kids
WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used…
Hospital’s campaign amid ‘severe flu season’
A hospital has called for people to take precautions to ease the burden on NHS services as the…
Preparing for the respiratory virus season: A guide for families
As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial…
Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season
Real-world data confirm that nirsevimab provides powerful protection for infants, reducing RSV hospital stays and easing the strain…